Conclusively in this study, we successfully constructed a novel integrated nanodrug FSGG/siGal-9 (Fe3O4@SiO2@PEG-PEI-glucose@GNR/Gal-9 siRNA) for transdermally treating melanoma via achieving PTIT. The gene discussed is LGALS9; the disease is melanoma.